Andrew Krahn

Concepts (193)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Long QT Syndrome8202110471.98Why?
Arrhythmias, Cardiac8202025101.41Why?
Defibrillators, Implantable620196241.13Why?
Electrocardiography10202139571.08Why?
Heart Arrest4201812391.05Why?
Cardiology Service, Hospital220206021.01Why?
Electrophysiologic Techniques, Cardiac420203960.94Why?
Anorexia Nervosa220191030.85Why?
Ethics, Institutional12020530.81Why?
Heart Rate6202115270.77Why?
Electrocardiography, Ambulatory120212040.76Why?
Diagnostic Techniques, Cardiovascular120201440.75Why?
Cardiovascular Surgical Procedures120202810.64Why?
Heart Conduction System220172660.63Why?
Wearable Electronic Devices220216940.62Why?
Antibiotic Prophylaxis120183990.60Why?
Prosthesis-Related Infections120183020.56Why?
Cardiovascular Diseases72020114970.55Why?
NAV1.5 Voltage-Gated Sodium Channel32018190.54Why?
Pacemaker, Artificial120184310.53Why?
Syncope420172380.53Why?
Cardiac Rehabilitation120205250.53Why?
Genetic Testing120173950.52Why?
Patient Care Management3202015140.52Why?
Cardiology6202028730.49Why?
Risk Management1202010440.47Why?
Stroke Volume3201821530.46Why?
Death, Sudden, Cardiac520195220.46Why?
Safety Management1202010930.45Why?
Tachycardia, Ventricular320192510.44Why?
Telerehabilitation120207360.44Why?
KCNQ1 Potassium Channel12009100.41Why?
Canada6202060180.38Why?
American Heart Association420203470.37Why?
Health Care Costs1201610070.36Why?
Catheter Ablation420204380.36Why?
Societies, Medical5202069070.32Why?
North America2202014000.29Why?
Ritonavir1202042120.28Why?
Azithromycin1202039430.28Why?
Models, Organizational220209080.27Why?
Equipment Failure220181970.24Why?
Brugada Syndrome22021980.24Why?
Cardiac Electrophysiology220202390.23Why?
Advisory Committees2201814180.23Why?
Heredity12021370.22Why?
Action Potentials320183680.22Why?
Pneumonia, Viral1020202436840.22Why?
Genetic Predisposition to Disease2202140270.22Why?
Coronavirus Infections1020202537890.21Why?
Pandemics1120203892490.21Why?
Electric Countershock220182840.21Why?
Referral and Consultation1201648160.21Why?
Organizational Innovation2202024680.20Why?
Bacitracin12018170.20Why?
Arrhythmogenic Right Ventricular Dysplasia12019560.19Why?
Cefazolin12018310.19Why?
Infection Control42020231310.19Why?
Cardiac Conduction System Disease12018440.18Why?
British Columbia220185120.18Why?
Calcium Channels, L-Type12017150.18Why?
Tachycardia, Supraventricular12018520.18Why?
Ryanodine Receptor Calcium Release Channel12017160.18Why?
Phenotype2202140370.17Why?
Predictive Value of Tests5202195370.17Why?
Channelopathies12017120.17Why?
Anticarcinogenic Agents12017250.17Why?
Delivery of Health Care22020159090.17Why?
Ventricular Fibrillation120181260.17Why?
Infectious Disease Transmission, Patient-to-Professional1202097060.16Why?
Registries12017123270.16Why?
Equipment Design4202130950.16Why?
Critical Care12020140810.16Why?
Anti-Bacterial Agents12018100830.16Why?
Leadership2202022410.16Why?
Polymorphism, Single Nucleotide1200936070.15Why?
Hydroxychloroquine12020124470.15Why?
Cell Transformation, Neoplastic120171910.15Why?
Cardiac Resynchronization Therapy120181910.15Why?
Risk Assessment82020254390.15Why?
Vancomycin120183280.15Why?
Humans4220219305980.15Why?
Cross-Over Studies120188670.15Why?
Survivors2201826190.15Why?
Genetic Association Studies120185590.14Why?
Atrial Fibrillation2201923200.13Why?
Health Services120207650.13Why?
Cardiomyopathies220179970.12Why?
Consensus4202063450.12Why?
Calcium120177080.12Why?
Costs and Cost Analysis120166940.12Why?
Drug Administration Schedule1201823240.11Why?
Mutation, Missense120178630.11Why?
Ventricular Function, Left2201815550.11Why?
Feasibility Studies1202134670.11Why?
Cardiovascular Agents120176630.11Why?
Exercise Test120179110.10Why?
Regional Medical Programs12009150.10Why?
Cluster Analysis1201830010.10Why?
Patient Selection3202045600.10Why?
Coronary Vessels120179140.10Why?
Male1420213677250.10Why?
Cardiovascular System120177500.09Why?
Female1320213803170.09Why?
Gain of Function Mutation22018540.09Why?
Heart Defects, Congenital120179330.09Why?
Betacoronavirus720202044540.09Why?
Middle Aged1120212706810.09Why?
Adult1020212443710.09Why?
Time Factors32021313970.08Why?
Monitoring, Physiologic1201819560.08Why?
Heart Failure2201866380.08Why?
Prospective Studies32021433010.08Why?
Cardiopulmonary Resuscitation1201918760.08Why?
Loss of Function Mutation220182440.08Why?
Odds Ratio1201758610.07Why?
Atrial Flutter120071430.07Why?
Patient Safety1202048850.07Why?
Risk Factors102019716210.07Why?
Follow-Up Studies32019170200.07Why?
Thromboembolism1201721010.07Why?
Blood Coagulation1201727680.07Why?
Reproducibility of Results12021113040.07Why?
Algorithms2201873460.07Why?
Occupational Health1202039650.06Why?
Logistic Models1201890890.06Why?
Clinical Decision-Making1201737550.06Why?
Ontario1200919660.06Why?
Anti-Arrhythmia Agents120053250.06Why?
Elective Surgical Procedures1202053380.06Why?
Mass Screening2202080050.06Why?
Morbidity2201814260.06Why?
Case-Control Studies12019176710.05Why?
Epicardial Mapping12019120.05Why?
Postoperative Complications1201858610.05Why?
Ion Channel Gating12017220.04Why?
Pulmonary Veins120191460.04Why?
Comorbidity22020347960.04Why?
Cardiac Imaging Techniques120203570.04Why?
Practice Guidelines as Topic22020154210.04Why?
Antiviral Agents22020417030.04Why?
Models, Cardiovascular120171530.04Why?
Health Surveys1200828410.04Why?
Signal Processing, Computer-Assisted120181930.04Why?
Anticoagulants1201795630.04Why?
Sodium120173090.04Why?
Organizational Policy120206940.04Why?
Return to Work120205790.03Why?
Aged520182157760.03Why?
Treatment Outcome52019517320.03Why?
Adrenergic beta-Agonists12012930.03Why?
Treatment Failure1201821060.03Why?
Retrospective Studies320191053220.03Why?
United States42020461500.03Why?
Gene Expression Regulation, Neoplastic1201710140.03Why?
Epinephrine120123230.02Why?
Adolescent12019868410.02Why?
Neoplasms12017172510.02Why?
Aged, 80 and over12018887590.02Why?
Biomarkers, Tumor1201713140.02Why?
Hospitalization12018542800.02Why?
Incidence12009256220.02Why?
Age Factors22018210390.02Why?
Guideline Adherence1201923090.02Why?
Asymptomatic Diseases1201834440.02Why?
Angiotensin Receptor Antagonists1202138920.02Why?
Young Adult22018937240.02Why?
Child32018700120.02Why?
HEK293 Cells1201783940.02Why?
Diagnosis, Differential1201872200.02Why?
Prognosis22017324900.02Why?
Clinical Laboratory Techniques22020234020.02Why?
Angiotensin-Converting Enzyme Inhibitors1202152770.02Why?
Ambulatory Care1202049470.02Why?
Dose-Response Relationship, Drug1201237760.01Why?
Research Design1201858300.01Why?
Hospitals12021117930.01Why?
Signal Transduction1201772070.01Why?
Randomized Controlled Trials as Topic12018106490.01Why?
Telemedicine22020250320.01Why?
Infant, Newborn12018231050.01Why?
Personal Protective Equipment12020159780.01Why?
Infant12018302740.01Why?
Cohort Studies12018360050.01Why?
Child, Preschool12018362830.01Why?
Global Health12017139110.01Why?
Evidence-Based Medicine1200532280.01Why?
Health Personnel12020296460.01Why?
Animals12017789310.01Why?
Primary Health Care1200548390.01Why?
Practice Patterns, Physicians'1200549270.01Why?
Clinical Trials as Topic1200573300.00Why?
Prevalence12005257730.00Why?
Krahn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (193)
Explore
_
Co-Authors (108)
Explore
_
Similar People (60)
Explore
_